ADHD Medications in Canada: Methylphenidate, Amphetamine Salts, and Costs

What Are ADHD Medications and How Do They Work?

Attention deficit hyperactivity disorder (ADHD) affects an estimated 1.5 million Canadians, including both children and adults. The most effective pharmacological treatments are stimulant medications, which work by increasing levels of dopamine and norepinephrine in the brain. These neurotransmitters are essential for attention, focus, and impulse control.

Two Main Stimulant Families

Methylphenidate-based medications block the reuptake of dopamine and norepinephrine. They come in immediate-release (IR) and extended-release (ER) formulations. Brand names include Ritalin (IR), Concerta (ER), and Biphentin (ER).

Amphetamine-based medications both block reuptake and increase the release of dopamine and norepinephrine, making them slightly more potent for some patients. Options include mixed amphetamine salts (Adderall XR) and lisdexamfetamine (Vyvanse).

Non-Stimulant Alternatives

For patients who cannot tolerate stimulants, atomoxetine (Strattera) and guanfacine (Intuniv) are available, though they are generally considered less effective than stimulants for core ADHD symptoms.

Brand vs Generic: Names and Pricing

ADHD medication pricing varies enormously depending on whether you use an IR generic or a brand-name extended-release product.

Immediate-release methylphenidate is by far the cheapest option, but it requires dosing two to three times per day, which can be challenging for children in school settings and adults at work. Extended-release formulations are more convenient but significantly more expensive.

Tips for Saving Money on ADHD Medications

• Consider IR formulations if feasible. Generic immediate-release methylphenidate can cost under $15 per month compared to $80+ for extended-release versions.
• Ask about generic extended-release options. Generic Concerta and Adderall XR are available and offer meaningful savings over brand names.
• Compare pharmacy prices on TransparentMedz. ADHD medications show some of the widest price variations between pharmacies.
• Check manufacturer patient assistance programs. Companies like Shire (Vyvanse) and Janssen (Concerta) offer copay cards and patient support programs.
• Use authorized generics when available. Some extended-release formulations have authorized generics that are identical to the brand product.

Canadian Pharmacare Coverage

ADHD medication coverage is inconsistent across provinces. Ontario's ODB covers generic methylphenidate IR and some ER formulations, but Vyvanse requires a Limited Use code. BC PharmaCare covers generic stimulants with Special Authority for some brand-name products. Quebec's RAMQ has the broadest ADHD medication coverage among provinces.

OHIP+ covers ADHD medications for Ontarians under 25, which is particularly important given that ADHD is commonly diagnosed in childhood and adolescence.

ADHD medications are not included in the first phase of national pharmacare, but their rising prescription rates among adults may push for broader public coverage in future phases.

The Bottom Line

ADHD medications range from very affordable (generic methylphenidate IR) to quite expensive (brand-name Vyvanse). Understanding the formulation differences and shopping around can save hundreds of dollars per year. Use TransparentMedz to compare prices at pharmacies near you and discuss generic options with your doctor.